Showing results (1851-1860 of 1,914) with videos related to

Sort By:
Pageof 192
The European Respiratory Journal|November 27, 2020
Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibodyHector Quijada, Tadeo Bermudez, Carrie L Kempf, et al.
Acta Neurochirurgica|February 24, 2001
A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular DiseaseD H Han, O K Kwon, B J Byun, et al.
The American Journal of Bioethics : AJOB|April 28, 2009
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challengesP S Duggan, A W Siegel, D M Blass, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
American Journal of Respiratory Cell and Molecular Biology|March 24, 2025
eNAMPT Is a Novel DAMP and Therapeutic Target in Human and Murine Pulmonary FibrosisNancy G Casanova, Jose D Herazo-Maya, Carrie L Kempf, et al.
Gut|March 26, 2015
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasisHui Ling, Karen Pickard, Cristina Ivan, et al.
AJR. American Journal of Roentgenology|November 19, 2025
Prevalence of Malignancy Among Incidental Indeterminate Adrenal Nodules on Contrast-Enhanced CT in Patients Without Known Cancer: A Multiinstitutional StudyMichael T Corwin, Mary L D Getz, Colin M Branson, et al.
The Review of Scientific Instruments|March 1, 2023
A flexible proton beam imaging energy spectrometer (PROBIES) for high repetition rate or single-shot high energy density (HED) experiments (invited)D A Mariscal, B Z Djordjević, R Anirudh, et al.
Blood|January 27, 2023
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid diseaseLivius Penter, Yang Liu, Jacquelyn O Wolff, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
Pageof 192